To include your compound in the COVID-19 Resource Center, submit it here.

Arcus raises upsized $120M IPO

Arcus Biosciences Inc. (NYSE:RCUS) raised on March 14 $120 million through the sale of 8 million shares at $15 in an upsized IPO underwritten

Read the full 241 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE